İlk 24 Saat | Meningokok Menenjiti

Meningokok Menenjiti Nedir?

Erken tanı ve uygun tedaviye rağmen, ilk semptomların ortaya çıkmasından sonraki 24–48 saat içinde vakaların yaklaşık %15’i ölümle sonuçlanabilmektedir. ^2,6

Meningokok hastalığının belirtileri gribe benzeyebilir ve hızla kötüleşebilir. ¹⁸ Bu nedenle belirtilere dikkat edilmelidir: ¹⁶

5 yaşın altındaki çocuklar: ateş¹⁶

5 yaşından büyük çocuklar: baş ağrısı¹⁶

Tüm yaş grupları: iştahsızlık, bulantı, kusma ve üst solunum yolu semptomları (boğaz ağrısı ve nezle).¹⁶

Bu belirtiler küçük çocuklarda yaklaşık 4 saat sürerken, ergenlerde 8 saate kadar uzayabilir. ¹⁶

Bundan sonra, ense sertliği, ışığa karşı hassasiyet ve şişkin bıngıldak dahil meningokok menenjitine özgü semptomlar başlar. Bu semptomların ortalama başlangıç süresi, hastalığın başlangıcından itibaren yaklaşık 12 ila 15 saattir. Son belirtiler (bilinç kaybı, deliryum veya nöbet gibi) 1 yaşından küçük bebeklerde ortalama 15 saat, daha büyük çocuklarda ise 24 saat civarında görülür. ¹⁶

Canadian Pediatric Society. Meningococcal Vaccine. Paediatr Child Health 2005;10(2).
World Health Organization. Meningococcal meningitis.2018. Available from: https://www.who.int/news-room/fact-sheets/detail/meningococcal -meningitis . Accessed 25 February 2021.
Centers for Disease Control and Prevention (CDC). Meningitis: About Bacterial Meningitis Infection, 2019. CDC website. https://www.cdc.gov/meningitis/about/bacterial-meningitis.html?CDC_AAref_Val=https://www.cdc.gov/meningitis/bacterial.html. Accessed 25 February 2021.
Centers for Disease Control and Prevention (CDC). Meningitis: Viral, 2019. CDC website. https://www.cdc.gov/meningitis/viral.html. Accessed 25 February 2021.
Centers for Disease Control and Prevention (CDC). Meningitis. CDC website. https://www.cdc.gov/meningitis/index.html. Accessed 25 February 2021.
World Health Organization. Weekly Epidemiological Record. 2011; 86: 521-54.
Zunt J, Kassebaum N, Blake N, Glennie L, Wright C, Nichols E et al. Global, regional, and national burden of meningitis, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet Neurology. 2018; 17(12): 1061-1082.
NHS. Meningitis Causes. 2019. Available from: https://www.nhs.uk/conditions/meningitis/causes/. Accessed 25 February 2021.
Purmohamad, A, Abasi E, Azimi T et al. Global estimate of Neisseria meningitidis serogroups proportion in invasive meningococcal disease: A systematic review and meta-analysis.Microb Pathog 2019 134:103571.
Viner R, Booy R, Johnson H, Edmunds W, Hudson L, Bedford H et al. Outcomes of invasive meningococcal serogroup B disease in children and adolescents (MOSAIC): a case-control study. The Lancet Neurology. 2012; 11(9):774-78.
Bettinger J, Scheifele D, Le Saux N, Halperin S, Vaudry W, Tsang R. The Disease Burden of Invasive Meningococcal Serogroup B Disease in Canada. The Pediatric Infectious Disease Journal. 2013;32(1):e20-e25.
Centers for Disease Control and Prevention. Meningococcal Surveillance 2019. Available from: https://www.cdc.gov/meningococcal/surveillance/index.html. Accessed 25 February 2021.
Bundy L, Noor A. Neonatal Meningitis. Ncbi.nlm.nih.gov. 2019. Available from: https://www.ncbi.nlm.nih.gov/books/NBK532264/ . Accessed 25 February 2021.
National Institutes of Health. Medline Plus. Meningococcal meningitis. https://medlineplus.gov/ency/article/000608.htm. Accessed 25 February 2021.
National Health Service (NHS). Meningitis: symptoms, 2019. NHS website. https://www.nhs.uk/conditions/meningitis/symptoms/. Accessed 25 February 2021.
Thompson M, Ninis N, Perera R, Mayon-White R, Phillips C, Bailey L et al. Clinical recognition of meningococcal disease in children and adolescents. The Lancet. 2006; 367(9508):397-4.
Villena R, Safadi M, Valenzuela M et al. Global epidemiology of serogroup B meningococcal disease and opportunities for prevention with novel recombinant protein vaccines. Human Vaccines & Immunotherapeutics 2018;14(5): 1042–1057.
Centers for Disease Control and Prevention . Meningococcal Signs and Symptoms. 2017. Available from: https://www.cdc.gov/meningococcal/about/symptoms.html. Accessed 25 February 2021.
NHS. Overview Meningitis. 2019. Available from: https://www.nhs.uk/conditions/meningitis/symptoms/ . Accessed 25 February 2021.
Centers for Disease Control and Prevention (CDC).Meningococcal: Causes and Transmission, 2019. CDC website. https://www.cdc.gov/meningococcal/about/causes-transmission.html. Accessed 25 February 2021.
ECDC. Surveillance Atlas of Infectious Diseases. 2018. Available from: https://atlas.ecdc.europa.eu/public/index.aspx. Accessed 25 February 2021.
National Organization for Rare Disorders (NORD). Meningococcal Meningitis, 2020. NORD website. https://rarediseases.org/rare-diseases/ meningococcalmeningitis/Accessed 25 February 2021.
Christensen H, May M, Bowen L, Hickman M, Trotter C. Meningococcal carriage by age: a systematic review and meta-analysis. The Lancet Infectious Diseases. 2010; 10(12): 853-861.
Memish Z, Goubeaud A, Bröker M, Malerczyk C, Shibl A. Invasive meningococcal disease and travel. Journal of Infection and Public Health. 2010; 3(4): 143-151.
Steffen R. The Risk of Meningococcal Disease in Travelers and Current Recommendations for Prevention. Journal of Travel Medicine.2010;17(suppl 1):9-17.
Choi C. Bacterial Meningitis in Aging Adults. Clinical Infectious Diseases. Clinical Infectious Diseases. 2001;33(8): 1380–1385.
For Every Child, Every Right: The Convention on the Rights of the Child at a crossroads. New York: United Nations Children’s Fund (UNICEF), 2019.
NHS. Why vaccination is safe and important. https://www.nhs.uk/conditions/vaccinations/why-vaccination-is-safe-and-important/. Accessed 25 February 2021.
Nigeria Centre for Disease Control (NCDC). World Meningitis Day 2019 - Life After Meningitis, 2019. NCDC website. https://ncdc.gov.ng/news/177/world-meningitis-day---2019-life-after-meningitis#: ~:text=Globally2%C20%Meningitis20%aects20%about202.8%,are20%currently20%aected20% in20%Nigeria. Accessed 25 February 2021.
Ceyhan M. et al. (2014) Meningitidis caused by Neisseria Meningitidis, Hemophilus Influenza Type B and Streptococcus Pneumoniae during 2005-2012 in Turkey. Human Vaccines & Immunotherapeautics, 10:9, 2706-2712.
Gökçay G., Beyazova U. (Ed) İlk Beş Yaşta Çocuk Sağlığı İzlemi. Sosyal Pediatri Yayınları
Huang L. et al. PLoS One. 2022,17:4,e0267786
Centers for disease control and prevention. Meningococcal Disease https://www.cdc.gov/meningococcal/about/prevention.html Erişim tarihi: 21.09.2023
Özdemir H and Çiftçi E. Meningococcal vaccines. J pediatr Inf 2014; 8: 178-86
T.C Sağlık Bakanlığı, Menenjit, https://hsgm.saglik.gov.tr/tr/hastaliklar/menenjit.html Erişim Tarihi: Nisan 2025